John Vandermosten

John Vandermosten, CFA

Senior Analyst

John Vandermosten, CFA is currently a Senior Analyst for Zacks Investment Research where he covers a portfolio of small-cap biotechnology names. His background includes 20 years of experience in a variety of investment management and research roles across all market cap ranges and throughout the capital structure. John is a frequent moderator of life sciences industry panels and his research articles have been posted extensively on Yahoo Finance News and throughout life sciences social media circles.

Formerly, John was a research analyst for Singular Research covering the healthcare space and a consultant with Coker Group, a national healthcare services firm providing financial advisory, investment banking, healthcare IT, and other services to hospitals and other healthcare organizations. At Coker Group he consulted with clients in a variety of strategic and financial areas, including asset valuations, due diligence, and transactions. Before his role as a sell-side analyst and consultant, John was a portfolio manager at Westwood Holdings Group and covered health care and other spaces as a research analyst. John also worked at the Teacher Retirement System of Texas as an investment analyst on the agency’s large-cap call overwriting fund.

John has an MBA from Texas A&M University, an MA from Tulane University and a BA from San Diego State University. He has also earned the Chartered Financial Analyst (CFA) designation and is a member of the CFA Society of Dallas.

John has covered firms in the following Sectors & Industries:
Healthcare: Biopharma, Infectious Diseases, Med-Tech, Oncology

Follow @vanjohn10

john vandermosten's universe includes